Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Antibodies 2013, 2(3), 392-414; doi:10.3390/antib2030392
Review

Antibody Glycosylation and Inflammation

 and *
Received: 3 April 2013; in revised form: 11 June 2013 / Accepted: 18 June 2013 / Published: 25 June 2013
(This article belongs to the Special Issue Modes of Antibody Action for Cancer Therapy)
View Full-Text   |   Download PDF [275 KB, uploaded 25 June 2013]
Abstract: IgG antibodies are the basis of some of the most effective therapeutics developed over the last 20 years. These antibodies are highly specific, have long serum-half lives, and can be produced relatively routinely, making them ideal drugs for immunotherapy. The degree of regulation on IgG antibody effector functions by the composition of the single, N-linked glycan attached to the Fc is increasingly appreciated. IgG antibodies with identical protein sequences can gain a 50-fold potency, in terms of initiating antibody-dependent cellular cytotoxicity (ADCC) by removal of the single fucose residue from the Fc glycan. Conversely, the addition of sialic acid to the terminus of the Fc glycan converts IgG antibodies into anti-inflammatory mediators, capable of suppressing autoantibody driven inflammation. This review will discuss the contribution of the Fc glycan to IgG antibody effector functions, the regulation of the antibody glycosylation in vivo, implications for the rational design of IgG antibody-based therapeutics, and touch upon the contribution of glycosylation to other immunoglobulin isotypes.
Keywords: immunoglobulin; ADCC; anti-inflammatory immunoglobulin; ADCC; anti-inflammatory
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Shade, K.-T.C.; Anthony, R.M. Antibody Glycosylation and Inflammation. Antibodies 2013, 2, 392-414.

AMA Style

Shade K-TC, Anthony RM. Antibody Glycosylation and Inflammation. Antibodies. 2013; 2(3):392-414.

Chicago/Turabian Style

Shade, Kai-Ting C.; Anthony, Robert M. 2013. "Antibody Glycosylation and Inflammation." Antibodies 2, no. 3: 392-414.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert